Ventricular Assist Devices Market Expected to Reach $2825.94 million by 2030 | CAGR of 8.6%

Ventricular assist devices are the mechanical pump, which is implanted in patients with heart failure. The main purpose of the ventricular assist device is to unload the failing heart and help maintain blood flow to vital organs. In case of bridge-to-transplant therapy or destination therapy, ventricular assist devices are typically placed through a chest incision after the patient has been placed on the bypass machine.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Abiomed, Inc.
Berlin Heart GmbH
Boston Scientific Corporation
Calon Cardio,
Jarvik Heart, Inc.
LivaNova PLC
Medtronic plc
ReliantHeart Inc.
Abbott Laboratories
Terumo Medical Corporation

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/2024

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By type, the left ventricular assist devices segment was the highest contributor to the ventricular assist devices market in 2020.
On the basis of indication, the bridge-to-transplant dominated the market in 2020, and is expected to continue this trend during the forecast period.
On the basis of Application, the transcutaneous ventricular assist devices segment dominated the ventricular assist device market in 2020, and is expected to continue this trend during the forecast period
Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/2024

For instance, in February 2020, Abbott received an approval from the U.S FDA for its fully implantable left ventricular assist system. As per the report published in the Journal of Geriatric Cardiology by Li-Yuan Ma, there were approximately 290 million patients of cardiovascular disorders in China and approximately 2 in 5 deaths occurred in China due to cardiovascular disorders. Therefore, the rise in number of cardiovascular diseases results in increase in number of organ transplantation procedures. This has led to increase in usage of ventricular assist devices that boosts the growth of the market. Ageing population is at a high risk of having cardiovascular diseases, which leads to increase in demand for surgical interventions. Thus, increase in geriatric population is also expected to drive the substantial growth of the ventricular assist devices market during forecast period.

The ventricular assist device market is segmented on the basis of product, application, design, and region. By product, it is divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). The segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number of cardiac surgeries, advancements in R&D activities in pharmaceutical & medical device industries, and surge in adoption of ventricular assist devices.

On the basis of application, the ventricular assist device market is classified into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. By design, the market is bifurcated into transcutaneous and implantable ventricular assist devices. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the global ventricular assist devices market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of cardiovascular surgeries, increase in number of approvals for ventricular assist products, presence of key players, and development in technology for healthcare in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in organ transplantation procedures, rise in number of geriatric populations, and growth in the healthcare industry.

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.